BioCentury
ARTICLE | Financial News

Sequenom jumps on outlook for MaterniT21 Plus

November 10, 2012 1:54 AM UTC

Sequenom Inc. (NASDAQ:SQNM) jumped $0.57 (19%) to $3.60 on Friday after disclosing in its 3Q12 earnings that the annualized run rate at the end of October for its MaterniT21 Plus laboratory-developed ...